Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001033427-07-000006
Filing Date
2007-01-10
Accepted
2007-01-10 11:37:30
Documents
2
Group Members
BANCIRELAND (US) HOLDINGS, INC.BIAM (US) INC.BIAM HOLDINGSIRIDIAN ASSET MANAGAMENT LLCTHE GOVERNOR AND COMPANY OF THE BANK OF IRELAND

Document Format Files

Seq Description Document Type Size
1 enzonpharm13g123106.txt SC 13G 22424
2 enzonex99.txt EX-99 2533
  Complete submission text file 0001033427-07-000006.txt   27370
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35587 | Film No.: 07522350
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST RD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

EIN.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G